GlaxoSmithkline Consumer Healthcare standalone net profit rises 8.42% in the March 2017 quarter

Sales rise 1.97% to Rs 1041.82 crore

Net profit of GlaxoSmithkline Consumer Healthcare rose 8.42% to Rs 175.88 crore in the quarter ended March 2017 as against Rs 162.22 crore during the previous quarter ended March 2016. Sales rose 1.97% to Rs 1041.82 crore in the quarter ended March 2017 as against Rs 1021.68 crore during the previous quarter ended March 2016.

For the full year,net profit declined 4.45% to Rs 656.67 crore in the year ended March 2017 as against Rs 687.28 crore during the previous year ended March 2016. Sales declined 4.07% to Rs 3773.94 crore in the year ended March 2017 as against Rs 3934.15 crore during the previous year ended March 2016.

 

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales1041.821021.68 2 3773.943934.15 -4 OPM %20.8420.93 -22.0921.30 - PBDT287.16263.67 9 1074.591113.39 -3 PBT269.46249.08 8 1010.411055.95 -4 NP175.88162.22 8 656.67687.28 -4

Powered by Capital Market - Live News